- Home
- SYBX vs DTSS Comparison
SYBX vs DTSS Comparison
Compare SYBX & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- DTSS
- Stock Information
- Founded
- SYBX N/A
- DTSS 2014
- Country
- SYBX United States
- DTSS China
- Employees
- SYBX N/A
- DTSS N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- DTSS Computer Software: Prepackaged Software
- Sector
- SYBX Health Care
- DTSS Technology
- Exchange
- SYBX Nasdaq
- DTSS Nasdaq
- Market Cap
- SYBX 16.5M
- DTSS 14.2M
- IPO Year
- SYBX N/A
- DTSS N/A
- Fundamental
- Price
- SYBX $1.36
- DTSS $2.33
- Analyst Decision
- SYBX Hold
- DTSS
- Analyst Count
- SYBX 1
- DTSS 0
- Target Price
- SYBX N/A
- DTSS N/A
- AVG Volume (30 Days)
- SYBX 19.0K
- DTSS 325.5K
- Earning Date
- SYBX 03-18-2025
- DTSS 02-13-2025
- Dividend Yield
- SYBX N/A
- DTSS N/A
- EPS Growth
- SYBX N/A
- DTSS N/A
- EPS
- SYBX N/A
- DTSS N/A
- Revenue
- SYBX $2,777,000.00
- DTSS $47,284,153.00
- Revenue This Year
- SYBX N/A
- DTSS N/A
- Revenue Next Year
- SYBX N/A
- DTSS N/A
- P/E Ratio
- SYBX N/A
- DTSS N/A
- Revenue Growth
- SYBX 292.23
- DTSS 117.51
- 52 Week Low
- SYBX $1.22
- DTSS $1.65
- 52 Week High
- SYBX $2.04
- DTSS $13.20
- Technical
- Relative Strength Index (RSI)
- SYBX 45.23
- DTSS 56.71
- Support Level
- SYBX $1.31
- DTSS $2.24
- Resistance Level
- SYBX $1.40
- DTSS $2.40
- Average True Range (ATR)
- SYBX 0.07
- DTSS 0.24
- MACD
- SYBX 0.00
- DTSS 0.03
- Stochastic Oscillator
- SYBX 60.61
- DTSS 48.62
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About DTSS Datasea Inc.
Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.